The global metaverse in surgical operations market size is calculated at USD 8.25 billion in 2024, grew to USD 10.84 billion in 2025 and is predicted to hit around USD 126.62 billion by 2034, expanding at a CAGR of 31.40% between 2024 and 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Metaverse in Surgical Operations Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Metaverse in Surgical Operations Market, by Component, 2024-2034
8.1.1. Hardware
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Software
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Service
8.1.3.1. Market Revenue and Forecast (2021-2034)
9.1. Metaverse in Surgical Operations Market, by Application, 2024-2034
9.1.1. Surgical Training
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Telesurgery
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Preoperative Planning
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2021-2034)
10.1. Metaverse in Surgical Operations Market, by Technology, 2024-2034
10.1.1. Virtual Reality (VR)
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Augmented Reality (AR)
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Mixed Reality (MR)
10.1.3.1. Market Revenue and Forecast (2021-2034)
11.1. Metaverse in Surgical Operations Market, by End User, 2024-2034
11.1.1. Hospitals and Surgical Centers
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Medical Training Institutes
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Telemedicine Providers
11.1.3.1. Market Revenue and Forecast (2021-2034)
12.1. North America
12.1.1. Market Revenue and Forecast, by Component (2021-2034)
12.1.2. Market Revenue and Forecast, by Application (2021-2034)
12.1.3. Market Revenue and Forecast, by Technology (2021-2034)
12.1.4. Market Revenue and Forecast, by End User (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Component (2021-2034)
12.1.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.1.5.3. Market Revenue and Forecast, by Technology (2021-2034)
12.1.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Component (2021-2034)
12.1.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.1.6.3. Market Revenue and Forecast, by Technology (2021-2034)
12.1.6.4. Market Revenue and Forecast, by End User (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Component (2021-2034)
12.2.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.3. Market Revenue and Forecast, by Technology (2021-2034)
12.2.4. Market Revenue and Forecast, by End User (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Component (2021-2034)
12.2.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.5.3. Market Revenue and Forecast, by Technology (2021-2034)
12.2.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Component (2021-2034)
12.2.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.6.3. Market Revenue and Forecast, by Technology (2021-2034)
12.2.6.4. Market Revenue and Forecast, by End User (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Component (2021-2034)
12.2.7.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.7.3. Market Revenue and Forecast, by Technology (2021-2034)
12.2.7.4. Market Revenue and Forecast, by End User (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Component (2021-2034)
12.2.8.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.8.3. Market Revenue and Forecast, by Technology (2021-2034)
12.2.8.4. Market Revenue and Forecast, by End User (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Component (2021-2034)
12.3.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.3. Market Revenue and Forecast, by Technology (2021-2034)
12.3.4. Market Revenue and Forecast, by End User (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Component (2021-2034)
12.3.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.5.3. Market Revenue and Forecast, by Technology (2021-2034)
12.3.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Component (2021-2034)
12.3.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.6.3. Market Revenue and Forecast, by Technology (2021-2034)
12.3.6.4. Market Revenue and Forecast, by End User (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Component (2021-2034)
12.3.7.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.7.3. Market Revenue and Forecast, by Technology (2021-2034)
12.3.7.4. Market Revenue and Forecast, by End User (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Component (2021-2034)
12.3.8.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.8.3. Market Revenue and Forecast, by Technology (2021-2034)
12.3.8.4. Market Revenue and Forecast, by End User (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Component (2021-2034)
12.4.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.3. Market Revenue and Forecast, by Technology (2021-2034)
12.4.4. Market Revenue and Forecast, by End User (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Component (2021-2034)
12.4.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.5.3. Market Revenue and Forecast, by Technology (2021-2034)
12.4.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Component (2021-2034)
12.4.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.6.3. Market Revenue and Forecast, by Technology (2021-2034)
12.4.6.4. Market Revenue and Forecast, by End User (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Component (2021-2034)
12.4.7.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.7.3. Market Revenue and Forecast, by Technology (2021-2034)
12.4.7.4. Market Revenue and Forecast, by End User (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Component (2021-2034)
12.4.8.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.8.3. Market Revenue and Forecast, by Technology (2021-2034)
12.4.8.4. Market Revenue and Forecast, by End User (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Component (2021-2034)
12.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.5.3. Market Revenue and Forecast, by Technology (2021-2034)
12.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Component (2021-2034)
12.5.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.5.5.3. Market Revenue and Forecast, by Technology (2021-2034)
12.5.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Component (2021-2034)
12.5.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.5.6.3. Market Revenue and Forecast, by Technology (2021-2034)
12.5.6.4. Market Revenue and Forecast, by End User (2021-2034)
13.1. Intuitive Surgical, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Medtronic Plc
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Siemens Healthineers AG
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Microsoft Corporation
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Novartis International AG
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Koninklijke Philips N.V.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Smith & Nephew Plc
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Immersion Corporation
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Hologic, Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. CAE Healthcare
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample